title: [CLINICAL CASES-TREATED WITH TECHNOLOGY LIPID COLLOIDAL (TLC)].
abstract: BACKGROUND
  This study presents clinical cases collecting etiologies that are more frequent in the field of complex wounds. All require a specific approach, as well as the interdisciplinary participation of different members of the team. But in general, established local cure plans may be quite similar. Applies them technology lipid colloidal (TLC) which consists of the combination of particles of hydrocolloid (carboxymethylcellulose) with lipid components. Products with a technology designed for every moment of healing.
  
  
  OBJECTIVE
  Show our experience in the use of products with TLC in patients with ulcers of different etiologies.
  
  
  METHODS
  The following products depending on the case have been used to treat: UrgoTul Absorb Border, Urgoclean (rope or plate), UrgoStart, UrgoK2 and UrgoK2 LITE. These products were applied in patients presenting four different etiologies of ulcer: hypertensive, traumatic, venous and ischemic ulcer. The use of Urgoclean rope favored cleaning the bed ulceral and applied Urgoclean plate with reinforced alginate to control the abundant exudates, with coverage of UrgoTul ABsorb Border. Once clean beds pass UrgoStart and at all times UrgoK2 bandage, cases that required compressive therapy. Intolerance to that kind of compression applied to patients presenting bandage UrgoK2 LITE (which tolerated without problem) which significantly reduced edema, favoring the control of exudate. Patients with ulcer of long evolution, at the start were reluctant to the application of new technologies, but after the first cures and sensing a good evolution, we get their confidence and commitment to the resolution.
  
  
  RESULTS
  Are displayed clinical cases of different etiologic and personal contexts that an integral and interdisciplinary approach together with the application of products with TLC, managed to solve the problem.
  
  
  CONCLUSIONS
  The materials used have been satisfactory in all cases, with a direct involvement in the resolution of lesions which carries a long unresolved, and in any of them, even with a diagnosis of poor prognosis. In the clinical practice of the wound care knowledge and research of new materials that improve the quality of life of patients, reducing the time evolution of the lesions is very important. Not to mention that education for the prevention of their health should be one of the objectives to prevent recurrences.
authors.forename: Dolores
authors.initials: D
authors.lastname: Hinojosa Caballero
authors.forename: Antònia
authors.initials: A
authors.lastname: Torres Subires
authors.forename: Lorenzo Ramón
authors.initials: LR
authors.lastname: Álvarez Rodríguez
authors.forename: Xènia
authors.initials: X
authors.lastname: Garrigós Sancristóbal
authors.forename: Maria Antònia
authors.initials: MA
authors.lastname: Pol Reyes
authors.forename: Elena
authors.initials: E
authors.lastname: Espejo Arenas
authors.forename: Montserrat
authors.initials: M
authors.lastname: Viturtia González
authors.forename: Sara
authors.initials: S
authors.lastname: Delgado Ballesteros
authors.forename: Cristina
authors.initials: C
authors.lastname: Sans Masip
authors.forename: Isabel
authors.initials: I
authors.lastname: Pascual-Malo
authors.forename: Meritxell
authors.initials: M
authors.lastname: Zaguirre Medina
authors.forename: Maribel
authors.initials: M
authors.lastname: Cuenda Macías
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D047070:Bandages, Hydrocolloid; D003102:Colloids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008055:Lipids / Q000627:therapeutic use*; D012883:Skin Ulcer / Q000188:drug therapy*
chemical_list: D003102:Colloids; D008055:Lipids